Cargando…
Genomic markers to tailor treatments: waiting or initiating?
The decade since the publication of the Human Genome Project draft has ended with the discovery of hundreds of genomic markers related to diseases and phenotypes. However, the project has not yet delivered on its promise to tailor treatments for individuals. The number of genomic markers in clinical...
Autores principales: | Tajik, Parvin, Bossuyt, Patrick M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128268/ https://www.ncbi.nlm.nih.gov/pubmed/21487770 http://dx.doi.org/10.1007/s00439-011-0986-9 |
Ejemplares similares
-
Evaluating Biomarkers for Guiding Treatment Decisions
por: Bossuyt, Patrick M., et al.
Publicado: (2015) -
Modifying mosquitoes to suppress disease transmission: Is the long wait over?
por: Powell, Jeffrey R
Publicado: (2022) -
Development and evaluating multimarker models for guiding treatment decisions
por: Tajik, Parvin, et al.
Publicado: (2018) -
Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
por: Horgan, Denis, et al.
Publicado: (2022) -
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)